Association of surgical margins with local recurrence in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy

被引:21
作者
Lin, Joseph [1 ,2 ]
Lin, Kuo-Juei [3 ]
Wang, Yu-Fen [4 ]
Huang, Ling-Hui [1 ]
Chen, Sam Li-Sheng [5 ]
Chen, Dar-Ren [1 ,4 ,6 ]
机构
[1] Changhua Christian Hosp, Comprehens Breast Canc Ctr, 135 Nanhsiao St, Changhua 500209, Taiwan
[2] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 407302, Taiwan
[3] I Shou Univ, E Da Hosp, Dept Surg, Kaohsiung 824410, Taiwan
[4] Changhua Christian Hosp, Canc Res Ctr, Dept Res, Changhua 500209, Taiwan
[5] Taipei Med Univ, Coll Oral Med, Sch Oral Hyg, Taipei 110301, Taiwan
[6] Chung Shan Med Univ, Sch Med, Taichung 402367, Taiwan
关键词
Neoadjuvant; Breast-conserving surgery; Surgical margin; Recurrence; PREOPERATIVE CHEMOTHERAPY; ADJUVANT BREAST; CARCINOMA LARGER; TUMOR RECURRENCE; CANCER PATIENTS; CONSERVATION; CONSENSUS; EXCISION; THERAPY; WOMEN;
D O I
10.1186/s12885-020-06955-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe aim of the current study was to report a single-institution experience using breast-conserving surgery after neoadjuvant chemotherapy (NACT), focusing on the association between microscopic resection margin status and locoregional recurrence (LRR).MethodsOur institutional prospectively maintained database was reviewed to identify patients who were treated with NACT between January 2008 and April 2018.ResultsAmong the main partial mastectomy specimens available for analysis (n=161), 28 had margins <1mm, 21 had margin width of 1-2mm and the remaining 112 had margins >2mm. LRR occurred in 16 patients (9.9%) and distant metastases were detected in 27 (16.8%) patients. There was no significant difference in the LRR between the >2mm margin group with a 60-month cumulative survival of 85.2% compared with 76.2% for the <= 2mm group (P= 0.335) in the Kaplan-Meier analysis. When we stratified patients by margin widths of >= 1mm or< 1mm, there was no LRR-free survival benefit observed for the <greater than or equal to>1mm pathologic excision margin group in the univariate analysis (hazard ratio=0.443; 95% confidence interval=0.142-1.383; P= 0.161) with a 60-month cumulative LRR-free survival of 84.9% compared with 69.5% for the <1mm margin cohort (P= 0.150).ConclusionsIn the absence of multiple scattered microscopic tumour foci, a negative margin of no ink on tumour maybe sufficient for stage I-III invasive breast cancer treated with NACT and breast-conserving surgery.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Association of surgical margins with local recurrence in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy
    Joseph Lin
    Kuo-Juei Lin
    Yu-Fen Wang
    Ling-Hui Huang
    Sam Li-Sheng Chen
    Dar-Ren Chen
    BMC Cancer, 20
  • [2] Margins in Breast-Conserving Surgery After Neoadjuvant Therapy
    Choi, Jungeun
    Laws, Alison
    Hu, Jiani
    Barry, William
    Golshan, Mehra
    King, Tari
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (12) : 3541 - 3547
  • [3] Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study
    Di Lena, Elise
    Iny, Ericka
    Wong, Stephanie M.
    Bassel, Miranda
    Shah, Arusa
    Basik, Mark
    Boileau, Jean-Francois
    Martel, Karyne
    Meterissian, Sarkis
    Prakash, Ipshita
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (10) : 6786 - 6794
  • [4] Breast-conserving surgery versus mastectomy for treatment of breast cancer after neoadjuvant chemotherapy
    Song, Yu-Chun
    Huang, Zhou
    Fang, Hui
    Tang, Yu
    Jing, Hao
    Song, Yong-Wen
    Jin, Jing
    Liu, Yue-Ping
    Chen, Bo
    Tang, Yuan
    Qi, Shu-Nan
    Lu, Ning-Ning
    Li, Ning
    Li, Ye-Xiong
    Wang, Shu-Lian
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery
    Woeste, Matthew R.
    Bhutiani, Neal
    Donaldson, Marilyn
    McMasters, Kelly M.
    Ajkay, Nicolas
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (02) : 439 - 445
  • [6] Can we predict local recurrence in breast conserving surgery after neoadjuvant chemotherapy?
    Cebrecos, I.
    Cordoba, O.
    Deu, J.
    Xercavins, J.
    Rubio, I. T.
    EJSO, 2010, 36 (06): : 528 - 534
  • [7] Local Recurrence after Breast-Conserving Surgery and Mastectomy Following Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer - a Meta-Analysis
    Zhou, Xiaodong
    Li, Yujie
    BREAST CARE, 2016, 11 (05) : 345 - 351
  • [8] "No Ink on Tumor" in Breast-Conserving Surgery after Neoadjuvant Chemotherapy
    Atzori, Giulia
    Gipponi, Marco
    Cornacchia, Chiara
    Diaz, Raquel
    Sparavigna, Marco
    Gallo, Maurizio
    Ruelle, Tommaso
    Murelli, Federica
    Franchelli, Simonetta
    Depaoli, Francesca
    Friedman, Daniele
    Fregatti, Piero
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (07):
  • [9] Survival After Breast-Conserving Surgery Compared with that After Mastectomy in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
    Gwark, Sungchan
    Kim, Hwa Jung
    Kim, Jisun
    Chung, Il Yong
    Kim, Hee Jeong
    Ko, Beom Seok
    Lee, Jong Won
    Son, Byung Ho
    Ahn, Sei Hyun
    Lee, Sae Byul
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (05) : 2845 - 2853
  • [10] Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy?
    Guo, Leqian
    Xie, Guilan
    Wang, Ruiqi
    Yang, Liren
    Sun, Landi
    Xu, Mengmeng
    Yang, Wenfang
    Chung, Mei Chun
    BMC CANCER, 2021, 21 (01)